174 related articles for article (PubMed ID: 37943631)
41. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM
Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794
[TBL] [Abstract][Full Text] [Related]
42. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM
Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581
[TBL] [Abstract][Full Text] [Related]
43. Treatment of Orbital Desmoid-type Fibromatosis With Sorafenib.
Downie EM; Amend CE; Miranda A; Burkat CN
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):e144-e147. PubMed ID: 35470290
[TBL] [Abstract][Full Text] [Related]
44. Abnormalities of the Wnt/β-catenin signalling pathway induce tumour progression in sporadic desmoid tumours: correlation between β-catenin widespread nuclear expression and VEGF overexpression.
Matono H; Tamiya S; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M; Oda Y
Histopathology; 2011 Sep; 59(3):368-75. PubMed ID: 22034877
[TBL] [Abstract][Full Text] [Related]
45. TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations.
Amini Nik S; Ebrahim RP; Van Dam K; Cassiman JJ; Tejpar S
Exp Cell Res; 2007 Aug; 313(13):2887-95. PubMed ID: 17601559
[TBL] [Abstract][Full Text] [Related]
46. Immunohistochemical and Molecular Analyses Focusing on Mesenchymal Cells in Papillary Thyroid Carcinoma with Desmoid-Type Fibromatosis.
Takada N; Mussazhanova Z; Hirokawa M; Nakashima M; Miyauchi A
Pathobiology; 2018; 85(5-6):300-303. PubMed ID: 30223266
[TBL] [Abstract][Full Text] [Related]
47. β-catenin S45F mutation results in apoptotic resistance.
Braggio D; Zewdu A; Londhe P; Yu P; Lopez G; Batte K; Koller D; Costas Casal de Faria F; Casadei L; Strohecker AM; Lev D; Pollock RE
Oncogene; 2020 Aug; 39(34):5589-5600. PubMed ID: 32651460
[TBL] [Abstract][Full Text] [Related]
48. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F
Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905
[TBL] [Abstract][Full Text] [Related]
49. β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
Colombo C; Belfiore A; Paielli N; De Cecco L; Canevari S; Laurini E; Fermeglia M; Pricl S; Verderio P; Bottelli S; Fiore M; Stacchiotti S; Palassini E; Gronchi A; Pilotti S; Perrone F
Mol Oncol; 2017 Nov; 11(11):1495-1507. PubMed ID: 28627792
[TBL] [Abstract][Full Text] [Related]
50. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour).
Hong H; Nadesan P; Poon R; Alman BA
Br J Cancer; 2011 Apr; 104(9):1452-8. PubMed ID: 21468052
[TBL] [Abstract][Full Text] [Related]
51. Activity of the Gamma Secretase Inhibitor AL101 in Desmoid Tumors: A Case Report of 2 Adult Cases.
Chan D; Kaplan J; Gordon G; Desai J
Curr Oncol; 2021 Sep; 28(5):3659-3667. PubMed ID: 34590610
[TBL] [Abstract][Full Text] [Related]
52. Desmoid tumor: from surgical extirpation to molecular dissection.
Lazar AJ; Hajibashi S; Lev D
Curr Opin Oncol; 2009 Jul; 21(4):352-9. PubMed ID: 19436199
[TBL] [Abstract][Full Text] [Related]
53. Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study.
Koike H; Nishida Y; Kohno K; Shimoyama Y; Motoi T; Hamada S; Kawai A; Ogose A; Ozaki T; Kunisada T; Matsumoto Y; Matsunobu T; Ae K; Gokita T; Sakai T; Shimizu K; Ishiguro N
Hum Pathol; 2019 Feb; 84():155-163. PubMed ID: 30292627
[TBL] [Abstract][Full Text] [Related]
54. Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM; Lefkowitz RA; Keohan ML; D'Adamo DR; Hameed M; Antonescu CR; Singer S; Stout K; Ahn L; Maki RG
Clin Cancer Res; 2011 Jun; 17(12):4082-90. PubMed ID: 21447727
[TBL] [Abstract][Full Text] [Related]
55. Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.
Xi Y; Wei Y; Sennino B; Ulsamer A; Kwan I; Brumwell AN; Tan K; Aghi MK; McDonald DM; Jablons DM; Chapman HA
Oncogene; 2013 Oct; 32(42):5048-57. PubMed ID: 23246962
[TBL] [Abstract][Full Text] [Related]
56. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group.
Gronchi A; Colombo C; Le Péchoux C; Dei Tos AP; Le Cesne A; Marrari A; Penel N; Grignani G; Blay JY; Casali PG; Stoeckle E; Gherlinzoni F; Meeus P; Mussi C; Gouin F; Duffaud F; Fiore M; Bonvalot S;
Ann Oncol; 2014 Mar; 25(3):578-583. PubMed ID: 24325833
[TBL] [Abstract][Full Text] [Related]
57. Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention.
van Broekhoven DL; Grünhagenl DJ; van Dalen T; van Coevorden F; Bonenkamp HJ; Been LB; Bemelmans MH; Dijkstra SD; Colombo C; Gronchi A; Verhoef C
BMC Cancer; 2016 Aug; 16(1):686. PubMed ID: 27565718
[TBL] [Abstract][Full Text] [Related]
58. [Biology and signaling pathways involved in the oncogenesis of desmoid tumors].
Salas S; Chibon F
Bull Cancer; 2020 Mar; 107(3):346-351. PubMed ID: 31955867
[TBL] [Abstract][Full Text] [Related]
59. Intra-abdominal desmoid fibromatosis mimicking tumour recurrence after the operation: A case series.
Nam KH; Kim B
Malays J Pathol; 2023 Apr; 45(1):111-122. PubMed ID: 37119251
[TBL] [Abstract][Full Text] [Related]
60. Sinonasal Myxoma: A Distinct Entity or a Myxoid Variant of Desmoid Fibromatosis?
Velez Torres JM; Mata DA; Briski LM; Green DC; Cloutier JM; Kerr DA; Montgomery EA; Rosenberg AE
Mod Pathol; 2023 Jul; 36(7):100189. PubMed ID: 37059229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
